NOVAGREEN IS APPROVED FOR COMMERCIAL USE BY THE ISRAELI MINISTRY OF HEALTH (YAKAR)
Results and Data analysis
safety and efficacy requirements prior approval for pilots and commercialization
![](https://novagreen-tech.com/wp-content/uploads/2020/03/Picture1-1024x548.png)
Summary of test results
Abbreviations
- *“HTHC”– High THC strain
- *“BLNC”– Balanced THC/CBD strain
- *“HCBD”– High CBD strain
All tests has been performed in a GMP certified lab.
All tests passed successfully but one that was done on old cannabis and had a positive Pseudomonas.
Device has been approved for SAFTY and EFFICACY.
Data in this presentation was submitted to the YAKAR.
![](https://novagreen-tech.com/wp-content/uploads/2020/03/Picture2.png)
No observation of visual changes in the treated cannabis.
Appearance
![](https://novagreen-tech.com/wp-content/uploads/2020/03/Picture4-1024x436.png)
Cannabinoids Analysis Post Treatment
No significant change in cannabinoids concentration post treatments.
* Allowed cannabinoids concentration in next slide
![](https://novagreen-tech.com/wp-content/uploads/2020/03/Picture5.png)
Allowed Cannabinoids Concentration
![](https://novagreen-tech.com/wp-content/uploads/2020/03/Picture6.png)
Foreign Materials Analysis
No foreign materials introduced in the treatment process.
![](https://novagreen-tech.com/wp-content/uploads/2020/03/Picture7.png)
Microbiology
Samples: three samples from three different batches from two different strains (high THC low CBD and high CBD low THC).
Success criteria: meets the criteria at the IMC-GMP 152, 7.7.
![](https://novagreen-tech.com/wp-content/uploads/2020/03/Picture8.png)
Toxins analysis
![](https://novagreen-tech.com/wp-content/uploads/2020/03/Picture9.png)